onasemnogene abeparvovec (Itvisma®)
Application Details
HSE100118
26025
onasemnogene abeparvovec
Itvisma®
Novartis Ireland Limited
06/07/2026
30/06/2026
Application Status
Awaiting Proposal from Applicant
02/09/2026
Applicant Meeting Held with CPU
02/09/2026
Rapid Review Completed
16/07/2026
Pricing and Reimbursement Application Complete
06/07/2026
Rapid Review Commissioned
20/05/2026